Stomach Cancer Treatment: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Stomach Cancer Treatment

Stomach Cancer Treatment represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Stomach Cancer Treatment Recommended?

• Newly diagnosed adenocarcinoma of the stomach or gastroesophageal junction (Stage 1 to 4).

• Locally advanced resectable gastric cancer (cT2-4, N+) requiring perioperative FLOT chemotherapy.

• HER2-positive metastatic gastric cancer requiring Trastuzumab + Chemotherapy.

• PD-L1 CPS ≥5 or MSI-High advanced gastric cancer requiring first-line Nivolumab/Pembrolizumab immunotherapy.

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Endoscopic Biopsy & Staging

High-definition Upper GI Endoscopy with multiple biopsies, HER2/PD-L1 IHC, and whole-body contrast CT.

Step 2: Perioperative FLOT Chemotherapy

Perioperative FLOT chemotherapy regimen in Day Care Chemotherapy unit.

Step 3: Radical D2 Surgical Resection

Radical D2 gastrectomy with lymphadenectomy performed in ISO Class-100 surgical suite.

Step 4: Adjuvant Completion & Surveillance

Completion of post-operative adjuvant chemotherapy and long-term dietary oncology follow-up.

Director's Signature Innovation: Comprehensive Multimodal Stomach Cancer Treatment

Dr. Neha Gupta delivers cutting-edge multimodal treatment for Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma. Incorporating standard-of-care Perioperative FLOT Chemotherapy (4 cycles before and 4 cycles after D2 gastrectomy to maximize cure), HER2 targeted therapy (Trastuzumab + Chemotherapy for HER2+ tumors), Claudin 18.2 targeted Zolbetuximab, and CheckMate-649 first-line Nivolumab immunotherapy for PD-L1 CPS ≥5 metastatic gastric cancer, overall survival and disease-free remission rates are significantly enhanced.

✔ Perioperative FLOT Regimen: Superior 5-year overall survival benchmark in resectable gastric cancer

✔ HER2 & PD-L1 CPS Testing: Upfront biomarker profiling matching patients to Trastuzumab or Nivolumab

✔ D2 Radical Gastrectomy Coordination: Complete oncological lymph node clearance for surgical cure

✔ Enteral Nutritional Support: Specialized oncology dietary regimens maintaining body mass post-gastrectomy

Recovery Timeline & Functional Milestones

Phase 1: Diagnostic Staging & Molecular Panel (Day 1 – 7)

Upper GI endoscopy biopsy, contrast CT chest/abdomen/pelvis, HER2/PD-L1/MSI panel, staging laparoscopy.

Phase 2: Neoadjuvant FLOT Phase (Month 1 – 2)

Neoadjuvant FLOT chemotherapy (4 cycles) in Daycare suite with anti-emetic and nutritional support.

Phase 3: D2 Surgical Resection (Month 3 – 4)

Radical D2 subtotal/total gastrectomy followed by surgical recovery and gradual diet advancement.

Phase 4: Adjuvant Completion & Remission (Month 5 – Long Term)

Completion of 4 post-op FLOT cycles, nutritional consolidation, and long-term survivorship surveillance.

Frequently Asked Clinical Questions (FAQs)

What is Perioperative FLOT chemotherapy for stomach cancer?

Perioperative chemotherapy (the FLOT regimen: 5-FU, Leucovorin, Oxaliplatin, Docetaxel) means giving 4 cycles of chemotherapy before surgery to shrink the stomach tumor and kill microscopic cancer cells in the bloodstream, followed by surgery, and then 4 more cycles after surgery. It provides the highest long-term cure rates globally.

Are there targeted therapies and immunotherapy for stomach cancer?

Yes. Approximately 15–20% of stomach cancers are HER2-positive (treated with Trastuzumab), and many express PD-L1 (treated with Nivolumab immunotherapy). Combining targeted biologics or immunotherapy with chemotherapy produces dramatic tumor shrinkage and prolonged survival in advanced gastric cancer.

Is Stomach Cancer Treatment cashless under Ayushman Bharat?

Yes, stomach cancer surgeries, D2 gastrectomies, FLOT chemotherapy, immunotherapy infusions, and inpatient care at Grover Hospital Bathinda are covered 100% cashless under PM-JAY Ayushman Bharat and 30+ private TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Stomach Cancer Treatment is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.